[HTML][HTML] Nanofiber scaffolds based on extracellular matrix for articular cartilage engineering: a perspective
Articular cartilage has a low self-repair capacity due to the lack of vessels and nerves. In
recent times, nanofiber scaffolds have been widely used for this purpose. The optimum …
recent times, nanofiber scaffolds have been widely used for this purpose. The optimum …
Advances in regenerative medicine and tissue engineering: innovation and transformation of medicine
Humans and animals lose tissues and organs due to congenital defects, trauma, and
diseases. The human body has a low regenerative potential as opposed to the urodele …
diseases. The human body has a low regenerative potential as opposed to the urodele …
[HTML][HTML] Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives
CR Harrell, BS Markovic, C Fellabaum… - Biomedicine & …, 2019 - Elsevier
Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …
progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions …
[HTML][HTML] Targeted and responsive biomaterials in osteoarthritis
J Li, H Zhang, Y Han, Y Hu, Z Geng, J Su - Theranostics, 2023 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is a degenerative disease characterized by loss of articular cartilage and
chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non …
chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non …
[HTML][HTML] Repair of damaged articular cartilage: current approaches and future directions
EV Medvedeva, EA Grebenik, SN Gornostaeva… - International journal of …, 2018 - mdpi.com
Articular hyaline cartilage is extensively hydrated, but it is neither innervated nor
vascularized, and its low cell density allows only extremely limited self-renewal. Most clinical …
vascularized, and its low cell density allows only extremely limited self-renewal. Most clinical …
[HTML][HTML] Articular cartilage regeneration in osteoarthritis
L Roseti, G Desando, C Cavallo, M Petretta, B Grigolo - Cells, 2019 - mdpi.com
There has been considerable advancement over the last few years in the treatment of
osteoarthritis, common chronic disease and a major cause of disability in older adults. In this …
osteoarthritis, common chronic disease and a major cause of disability in older adults. In this …
Matrix-applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial
M Brittberg, D Recker, J Ilgenfritz… - … American journal of …, 2018 - journals.sagepub.com
Background: Matrix-based cell therapy improves surgical handling, increases patient
comfort, and allows for expanded indications with better reliability within the knee joint. Five …
comfort, and allows for expanded indications with better reliability within the knee joint. Five …
Recent progress in the fabrication techniques of 3D scaffolds for tissue engineering
Significant advances have been made in the field of tissue engineering (TE), especially in
the synthesis of three-dimensional (3D) scaffolds for replacing damaged tissues and organs …
the synthesis of three-dimensional (3D) scaffolds for replacing damaged tissues and organs …
[HTML][HTML] Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling
Cell therapies offer a tailorable, personalized treatment for use in tissue engineering to
address defects arising from trauma, inefficient wound repair, or congenital malformation …
address defects arising from trauma, inefficient wound repair, or congenital malformation …
Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis
Osteoarthritis (OA) is a chronic joint disease characterized by progressive degeneration of
articular cartilage. A challenge in the development of disease-modifying drugs is effective …
articular cartilage. A challenge in the development of disease-modifying drugs is effective …